Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,594 | 25 | 89.4% |
| Travel and Lodging | $3,452 | 11 | 6.8% |
| Food and Beverage | $1,761 | 44 | 3.5% |
| Education | $176.99 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $49,546 | 49 | $0 (2024) |
| Galderma Laboratories, L.P. | $540.54 | 8 | $0 (2023) |
| Allergan, Inc. | $221.56 | 4 | $0 (2022) |
| ABBVIE INC. | $193.11 | 8 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $188.01 | 4 | $0 (2020) |
| Janssen Biotech, Inc. | $97.28 | 2 | $0 (2024) |
| GENZYME CORPORATION | $40.74 | 2 | $0 (2020) |
| Mentor Worldwide LLC | $31.90 | 1 | $0 (2024) |
| Amgen Inc. | $31.85 | 1 | $0 (2020) |
| Celgene Corporation | $24.23 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,209 | 35 | Lilly USA, LLC ($29,997) |
| 2023 | $19,874 | 24 | Lilly USA, LLC ($19,525) |
| 2022 | $221.56 | 4 | Allergan, Inc. ($221.56) |
| 2021 | $133.35 | 1 | Galderma Laboratories, L.P. ($133.35) |
| 2020 | $280.94 | 9 | MERZ NORTH AMERICA, INC. ($148.00) |
| 2019 | $249.19 | 9 | Galderma Laboratories, L.P. ($109.62) |
| 2018 | $16.38 | 1 | GENZYME CORPORATION ($16.38) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/27/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 09/27/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $432.01 | General |
| 09/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.01 | General |
| 08/26/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $468.75 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $122.40 | General |
| 06/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Immunology | ||||||
| 05/17/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $227.80 | General |
| 05/09/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Immunology | ||||||
| 05/03/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $341.69 | General |
| 05/03/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Immunology | ||||||
| 04/30/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $113.51 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 04/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $96.45 | General |
| 04/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Immunology | ||||||
| 03/14/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 55 | 72 | $28,961 | $5,806 |
| 2022 | 5 | 107 | 187 | $39,573 | $7,948 |
| 2021 | 7 | 163 | 309 | $49,305 | $10,140 |
| 2020 | 5 | 87 | 104 | $24,380 | $4,767 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 59 | $22,483 | $4,457 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,478 | $1,348 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 63 | $23,661 | $5,072 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 26 | 30 | $7,750 | $1,413 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $3,741 | $733.60 | 19.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 15 | 17 | $3,292 | $633.82 | 19.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2022 | 14 | 66 | $1,130 | $95.44 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 27 | 45 | $16,110 | $3,602 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 42 | 54 | $13,176 | $3,003 | 22.8% |
| 17000 | Destruction of skin growth | Facility | 2021 | 27 | 31 | $5,549 | $1,404 | 25.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 18 | 18 | $6,426 | $1,120 | 17.4% |
| 11104 | Punch biopsy of single skin lesion | Facility | 2021 | 12 | 13 | $3,640 | $481.40 | 13.2% |
| 11102 | Tangential biopsy of single skin lesion | Facility | 2021 | 13 | 14 | $3,332 | $299.34 | 9.0% |
| 17003 | Destruction of 2-14 skin growths | Facility | 2021 | 24 | 134 | $1,072 | $230.00 | 21.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 23 | $8,234 | $1,597 | 19.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 21 | 21 | $7,497 | $1,337 | 17.8% |
| 17000 | Destruction of skin growth | Facility | 2020 | 19 | 21 | $3,759 | $916.70 | 24.4% |
| 17110 | Destruction of up to 14 skin growths | Facility | 2020 | 12 | 14 | $4,690 | $869.40 | 18.5% |
| 17003 | Destruction of 2-14 skin growths | Facility | 2020 | 12 | 25 | $200.00 | $47.22 | 23.6% |
About Dr. Farah Moustafa, MD
Dr. Farah Moustafa, MD is a Internal Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2015. The National Provider Identifier (NPI) number assigned to this provider is 1679954853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farah Moustafa, MD has received a total of $50,984 in payments from pharmaceutical and medical device companies, with $30,209 received in 2024. These payments were reported across 83 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,594).
As a Medicare-enrolled provider, Moustafa has provided services to 412 Medicare beneficiaries, totaling 672 services with total Medicare billing of $28,661. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Dermatology
- Location Providence, RI
- Active Since 06/14/2015
- Last Updated 07/28/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679954853
Products in Payments
- OLUMIANT (Drug) $45,916
- BOTOX (Biological) $221.56
- TALTZ (Drug) $177.50
- XEOMIN (Biological) $137.01
- RINVOQ (Biological) $80.21
- TREMFYA (Drug) $79.99
- Otezla (Drug) $56.08
- MENTOR MemoryGel Resterilizable Gel Sizer (Device) $31.90
- DUPIXENT (Biological) $24.36
- Avar (Drug) $24.02
- EUCRISA (Drug) $23.82
- COSENTYX (Biological) $21.14
- Tremfya (Drug) $17.29
- DUPIXENT (Drug) $16.38
- Humira (Biological) $12.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Providence
Randall Ingham, M.d, M.D
Internal Medicine — Payments: $154,470
Monica Dhakar, M.d, M.D
Internal Medicine — Payments: $47,405
Hajra Awwab, Md, MD
Internal Medicine — Payments: $41,418
Richard Ruggieri, M.d, M.D
Internal Medicine — Payments: $36,352
Dr. Peter Barth, M.d, M.D
Internal Medicine — Payments: $29,192
Jeffrey Lawrence, M.d, M.D
Internal Medicine — Payments: $23,037